| 000 | 01584 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516102807.0 | ||
| 264 | 0 | _c20121123 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1941-7705 | ||
| 024 | 7 |
_a10.1161/CIRCOUTCOMES.112.966150 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEapen, Zubin J | |
| 245 | 0 | 0 |
_aDefining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward. _h[electronic resource] |
| 260 |
_bCirculation. Cardiovascular quality and outcomes _cJul 2012 |
||
| 300 |
_a594-600 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 | _aEndpoint Determination |
| 650 | 0 | 4 |
_aHeart Failure _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 |
_aMyocardial Revascularization _xadverse effects |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTerminology as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTang, W H Wilson | |
| 700 | 1 | _aFelker, G Michael | |
| 700 | 1 | _aHernandez, Adrian F | |
| 700 | 1 | _aMahaffey, Kenneth W | |
| 700 | 1 | _aLincoff, A Michael | |
| 700 | 1 | _aRoe, Matthew T | |
| 773 | 0 |
_tCirculation. Cardiovascular quality and outcomes _gvol. 5 _gno. 4 _gp. 594-600 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCOUTCOMES.112.966150 _zAvailable from publisher's website |
| 999 |
_c21957773 _d21957773 |
||